Join to View Full Profile
3100 Plaza Properties BlvdColumbus, OH 43219
Phone+1 614-383-6000
Fax+1 614-383-6001
Are you Dr. Knapp?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Mark Knapp, MD is an oncologist in Columbus, Ohio. He is currently licensed to practice medicine in Ohio and Kentucky.
Education & Training
- University of Cincinnati Medical Center/College of MedicineFellowship, Hematology and Medical Oncology, 2000 - 2003
- Ascension St Vincent Hospital IndianapolisResidency, Internal Medicine, 1997 - 2000
- University of Cincinnati College of MedicineClass of 1997
Certifications & Licensure
- OH State Medical License 2000 - 2026
- KY State Medical License 2001 - 2002
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 18 citationsThe combination of ibrutinib and rituximab demonstrates activity in first-line follicular lymphoma.Nathan Fowler, Loretta J. Nastoupil, Sven de Vos, Mark Knapp, Ian W. Flinn
British Journal of Haematology. 2020-03-16 - 99 citationsIbrutinib plus lenalidomide and rituximab has promising activity in relapsed/refractory non-germinal center B-cell-like DLBCLAndre Goy, Radhakrishnan Ramchandren, Nilanjan Ghosh, Javier Munoz, David S. Morgan
Blood. 2019-09-26 - 46 citationsSWOG S1400B (NCT02785913), a Phase II Study of GDC-0032 (Taselisib) for Previously Treated PI3K-Positive Patients with Stage IV Squamous Cell Lung Cancer (Lung-MAP Sub...Corey J. Langer, Mary W. Redman, James L. Wade, Charu Aggarwal, Jeffrey D. Bradley
Journal of Thoracic Oncology. 2019-05-31